SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-22-000150
Filing Date
2022-11-10
Accepted
2022-11-10 17:00:19
Documents
47
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20220930.htm   iXBRL 10-Q 736830
2 EX-31.1 slrx20220930ex-311.htm EX-31.1 8965
3 EX-31.2 slrx20220930ex-312.htm EX-31.2 8763
4 EX-32.1 slrx20220930ex-321.htm EX-32.1 6453
  Complete submission text file 0001615219-22-000150.txt   3297993

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20220930.xsd EX-101.SCH 19238
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20220930_cal.xml EX-101.CAL 29669
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20220930_def.xml EX-101.DEF 95351
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20220930_lab.xml EX-101.LAB 310867
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20220930_pre.xml EX-101.PRE 200406
41 EXTRACTED XBRL INSTANCE DOCUMENT flks-20220930_htm.xml XML 423126
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 221378262
SIC: 2834 Pharmaceutical Preparations